d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders

Danilo De Gregorio(University of Campania "Luigi Vanvitelli"), Gabriella Gobbi(McGill University), Luca Posa(Montreal Neurological Institute and Hospital), Justine P. Enns(McGill University), Nicolás A. Núñez(Mayo Clinic)
Progress in brain research
January 1, 2018
10.1016/bs.pbr.2018.07.008
Cited by 95

Related Papers

Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood
|JAMA Psychiatry|2019|911
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
|Proceedings of the National Academy of Sciences|2005|677
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
|Pain|2018|395
Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
|Pharmacological Reviews|2018|386
Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype
|Nature Neuroscience|2006|373